Vontobel Holding
ATRA icon

Vontobel Holding’s Atara Biotherapeutics ATRA Stock Holding History

Vontobel Holding’s Portfolio ATRA Stock Details ATRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,200
Closed -$55.5K – 1079
2024
Q1 		$55.5K Hold
3,200
– – ﹤0.01% 1049
2023
Q4 		$41K Buy
+3,200
New +$74.6K ﹤0.01% 1074
2021
Q4 		– Sell
-800
Closed -$358K – 1058
2021
Q3 		$358K Hold
800
– – ﹤0.01% 896
2021
Q2 		$311K Hold
800
– – ﹤0.01% 905
2021
Q1 		$287K Buy
800
+80
+11% +$35.4K ﹤0.01% 822
2020
Q4 		$353K Buy
+720
New +$332K ﹤0.01% 760

Other funds holding ATRA

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
CC
Centiva Capital New York $11.5B AUM 31.97% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

Vontobel Holding's ATRA Position: Q2 2024 in Review

Vontobel Holding sold out of Atara Biotherapeutics (ATRA) in Q2 2024, closing a stake of 3,200 shares — an estimated $55.5K sold.

Vontobel Holding first reported a position in ATRA in Q4 2020 and held it in 6 quarters. The position peaked at $358K in Q3 2021. 48 funds tracked by Wall St. Rank hold ATRA as of Q2 2024.

  • Vontobel Holding reported no remaining Atara Biotherapeutics position as of Q2 2024 after selling out during the quarter.
  • Vontobel Holding sold 3,200 Atara Biotherapeutics shares in Q2 2024, an estimated $55.5K.
  • Vontobel Holding first reported a position in Atara Biotherapeutics in Q4 2020 and held it in 6 quarters.
  • Vontobel Holding's Atara Biotherapeutics position peaked at $358K in Q3 2021.
  • 48 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q2 2024.

Based on Vontobel Holding's 13F filing for Q2 2024, filed 13 Aug 2024.